Advertisement

Trends in cancer mortality at age 15 to 24 years in Europe

  • F. Levi
    Correspondence
    Corresponding author
    Affiliations
    Registre Vaudois des Tumeurs, and Unité d'Epidémiologie du Cancer, Institut Universitaire de Médecine Sociale et Préventive, CHUV-Falaises 1, 1011 Lausanne, Switzerland
    Search for articles by this author
  • F. Lucchini
    Affiliations
    Registre Vaudois des Tumeurs, and Unité d'Epidémiologie du Cancer, Institut Universitaire de Médecine Sociale et Préventive, CHUV-Falaises 1, 1011 Lausanne, Switzerland
    Search for articles by this author
  • E. Negri
    Affiliations
    Istituto di Ricerche Farmacologiche “Mario Negri”, Via Eritrea 62, 20157 Milan, Italy
    Search for articles by this author
  • C. La Vecchia
    Affiliations
    Registre Vaudois des Tumeurs, and Unité d'Epidémiologie du Cancer, Institut Universitaire de Médecine Sociale et Préventive, CHUV-Falaises 1, 1011 Lausanne, Switzerland

    Istituto di Ricerche Farmacologiche “Mario Negri”, Via Eritrea 62, 20157 Milan, Italy

    Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Via Venezian 1, 20133 Milan, Italy
    Search for articles by this author

      Abstract

      Trends in death certification rates from all cancers and seven selected cancer sites (bone sarcoma, soft-tissue sarcoma, ovary, testis, non-Hodgkin's lymphomas, Hodgkin's disease, leukaemias) were analysed for the population aged 15–24 years in Europe and, for comparative purposes, in the United States of America (USA) and Japan over the period of 1965–1998. Overall, there was a decrease in total cancer mortality of approximately 40% for both sexes. The declined mortality is largely attributable to better treatments and inclusion in multicentre clinical trials. The degree of improvement was similar in Japan and the USA, but was less in Eastern European countries, reflecting delays in the application of effective treatments, and limited involvement in large, well-designed clinical trials for these curable cancers in Eastern Europe.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Becker N.
        • Boyle P.
        Decline in mortality from testicular cancer in West Germany after reunification.
        Lancet. 1997; 350: 744
        • La Vecchia C.
        • Levi F.
        • Lucchini F.
        • Lagiou P.
        • Trichopoulos D.
        • Negri E.
        Trends in childhood cancer mortality as indicators of quality in medical care in the developed world.
        Cancer. 1998; 83: 2223-2227
        • Levi F.
        • La Vecchia C.
        • Negri E.
        • Lucchini F.
        Childhood cancer mortality in Europe, 1955–1995.
        Eur. J. Cancer. 2001; 37: 785-809
        • Levi F.
        • Lucchini F.
        • Negri E.
        • Barbui T.
        • La Vecchia C.
        Trends in mortality from leukemia in subsequent age groups.
        Leukemia. 2000; 14: 1980-1985
        • Levi F.
        • Lucchini F.
        • Negri E.
        • Boyle P.
        • La Vecchia C.
        Trends in mortality from Hodgkin's disease in western and eastern Europe.
        Br. J. Cancer. 2002; 87: 291-293
        • McNally R.J.
        • Roman E.
        • Cartwright R.A.
        Leukemias and lymphomas.
        Cancer Causes Control. 1999; 10: 35-42
        • Levi F.
        • La Vecchia C.
        • Boyle P.
        • Lucchini F.
        • Negri E.
        Western and eastern European trends in testicular cancer mortality.
        Lancet. 2001; 357: 1853-1854
        • Martos M.C.
        • Winther J.F.
        • Olsen J.H.
        Cancer among teenagers in Denmark, 1943–1987.
        Int. J. Cancer. 1993; 55: 57-62
        • Levi F.
        • La Vecchia C.
        • Randimbison L.
        • Te V.C.
        Cancer incidence and mortality in young adults in Vaud, Switzerland, 1974–1992.
        Int. J. Cancer. 1995; 61: 606-610
        • Franceschi S.
        • Levi F.
        • Lucchini F.
        • Negri E.
        • Boyle P.
        • La Vecchia C.
        Trends in cancer mortality in young adults in Europe, 1955–1989.
        Eur. J. Cancer. 1994; 30: 2096-2118
        • Stiller C.A.
        • Stevens M.C.G.
        • Magnani C.
        • Corazziari I.
        • the EUROCARE Working Group
        Survival of children with soft-tissue sarcoma in Europe since 1978.
        Eur. J. Cancer. 2001; 37: 767-774
        • Levi F.
        • La Vecchia C.
        • Randimbison L.
        • Te V.C.
        Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland.
        Eur. J. Cancer. 1999; 35: 1711-1716
        • Stiller C.A.
        Population based survival rates for childhood cancer in Britain, 1980–91.
        Br. Med. J. 1994; 309: 1612-1616
        • Stiller C.A.
        • Craft A.W.
        • Corazziari I.
        Survival of children with bone sarcoma in Europe since 1978.
        Eur. J. Cancer. 2001; 36: 760-766
        • Stiller C.A.
        • Parkin D.M.
        Geographic and ethnic variations in the incidence of childhood cancer.
        Br. Med. Bull. 1996; 52: 682-703